Can a Patient on Amlodipine Safely Receive a Single Dose of Ketorolac (Toradol) Injection?
Yes, a patient taking amlodipine can safely receive a one-time ketorolac (Toradol) injection, as there is no direct drug interaction between these medications and evidence suggests potential additive analgesic benefit.
Evidence Supporting Safety
The combination of amlodipine and ketorolac has been specifically studied and demonstrates no contraindication. Research shows that amlodipine actually exhibits additive antinociceptive (pain-relieving) effects when combined with ketorolac, potentially through decreased cellular calcium availability 1. This suggests not only safety but possible enhanced analgesic efficacy.
From a pharmacokinetic perspective, amlodipine is a calcium channel blocker that causes vasodilation and has renoprotective effects, even demonstrating increased eGFR with single doses 2. Ketorolac is an NSAID with well-established efficacy for acute pain management 3, 4.
Clinical Considerations Before Administration
Check for NSAID-specific contraindications (these apply regardless of amlodipine use):
- Renal function: Avoid if creatinine is significantly elevated or patient has severe renal impairment
- GI risk factors: History of peptic ulcer disease, GI bleeding, or age >60 years increases risk 5
- Cardiovascular disease: History of cardiovascular disease or bleeding disorders 5
- Aspirin/NSAID-induced asthma 3
- Pregnancy 3
- Current anticoagulation therapy (warfarin, heparin) 5
Dosing for Single Injection
Per FDA labeling 4:
For patients <65 years:
- IM: 60 mg single dose
- IV: 30 mg single dose (over at least 15 seconds)
For patients ≥65 years, renally impaired, or <50 kg:
- IM: 30 mg single dose
- IV: 15 mg single dose
Monitoring Recommendations
Ensure adequate hydration status before administration 4. Hypovolemia should be corrected prior to ketorolac administration to minimize renal risk.
For a single dose in an otherwise healthy patient on amlodipine, no specific additional monitoring beyond standard post-injection observation is required. The analgesic effect begins in approximately 30 minutes with maximum effect at 1-2 hours and duration of 4-6 hours 4.
Safety Data
Recent evidence in geriatric patients (≥65 years) showed that single-dose parenteral ketorolac was not associated with increased cardiovascular, gastrointestinal, or renal adverse outcomes compared to matched controls 6. The primary composite adverse event rate was actually lower in the ketorolac group (1.7% vs 3.9%, though not statistically significant) 6.
Important Caveats
- Do not exceed 5 days total duration if transitioning to oral ketorolac 4
- Amlodipine's renoprotective effects may theoretically provide some buffer against NSAID-related renal effects 2, though this should not encourage use in patients with contraindications
- The combination has been studied primarily for analgesic efficacy rather than long-term safety, so this recommendation applies specifically to single-dose or short-term use
Bottom line: Proceed with the single ketorolac injection if no NSAID-specific contraindications exist. The amlodipine does not preclude ketorolac use and may actually enhance analgesic efficacy.